Evidence map›Paper›PMID 38067141›Full record

ArticleCells2023

Vajihe Azimian Zavareh, Shima Gharibi, Mahnaz Hosseini Rizi, Abdolhossein Nekookar, Hossein Mirhendi, Mehdi Rahimmalek, Antoni Szumny

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Cancer Stem Cells from Definition to Detection and Targeted Drugs.International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Vajihe Azimian ZavarehCore Research Facilities (CRF), Isfahan University of Medical Sciences, Isfahan 81746-73461, Iran.
Shima GharibiCore Research Facilities (CRF), Isfahan University of Medical Sciences, Isfahan 81746-73461, Iran.
Mahnaz Hosseini RiziCore Research Facilities (CRF), Isfahan University of Medical Sciences, Isfahan 81746-73461, Iran.ORCID 0000-0001-6175-0436
Abdolhossein NekookarCore Research Facilities (CRF), Isfahan University of Medical Sciences, Isfahan 81746-73461, Iran.
Hossein MirhendiCore Research Facilities (CRF), Isfahan University of Medical Sciences, Isfahan 81746-73461, Iran.
Mehdi RahimmalekDepartment of Horticulture, College of Agriculture, Isfahan University of Technology, Isfahan 84156-83111, Iran.ORCID 0000-0001-5853-8362
Antoni SzumnyDepartment of Food Chemistry and Biocatalysis, Wroclaw University of Environmental and Life Sciences, 50-375 Wrocław, PolandORCID 0000-0001-9058-1598

Funding

Isfahan University of Medical Sciences, Isfahan, Iran grant number 199364
6 · The paper itself

Abstract

Overcoming drug resistance and specifically targeting cancer stem cells (CSCs) are critical challenges in improving cancer therapy. Nowadays, the use of novel and native medicinal plants can provide new sources for further investigations for this purpose. The aim of this study was to assess the potential of

Indexed as

Breast NeoplasmsGlioblastomaSaturejaApoptosisFemaleHumansNeoplastic Stem Cellsbreast cancercancer stem cellsglioblastomamedicinal plantsSatureja bachtiaricaspheroid

Identifiers

PMID38067141
PMCPMC10706021

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.